Improved risk stratification by the integration of the revised International Prognostic Scoring System with the Myelodysplastic Syndromes Comorbidity Index-Reference-Cited by-同舟云学术

Improved risk stratification by the integration of the revised International Prognostic Scoring System with the Myelodysplastic Syndromes Comorbidity Index

Published:2014-12 Issue:18 Volume:50 Page:3198-3205
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

van Spronsen M.F.,Ossenkoppele G.J.,Holman R.,van de Loosdrecht A.A.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference30 articles.

1. Myelodysplastic syndromes–coping with ineffective hematopoiesis;Cazzola;N Engl J Med,2005

2. The genetic basis of phenotypic heterogeneity in myelodysplastic syndromes;Raza;Nat Rev Cancer,2012

3. Myelodysplastic syndromes: 2011 update on diagnosis, risk-stratification, and management;Garcia-Manero;Am J Hematol,2011

4. The multifaceted nature of myelodysplastic syndromes: clinical, molecular, and biological prognostic features;Greenberg;J Natl Compr Canc Netw,2013

5. Prognostic classification and risk assessment in myelodysplastic syndromes;Cazzola;Hematol Oncol Clin North Am,2010

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A case of destination therapy for post-fulminant myocarditis with myelodysplastic syndrome;Journal of Artificial Organs;2024-06-11

2. MDS-Comorbidity Index using register data has prognostic impact in Swedish MDS patients;Leukemia Research;2023-11

3. Impact of Frailty on Health Care Resource Utilization and Costs of Care in Myelodysplastic Syndromes;JCO Oncology Practice;2023-04

4. Myelodysplasia;Pathy's Principles and Practice of Geriatric Medicine;2022-02-18

5. Comorbidities and frailty predict outcome of patients with myelodysplastic syndromes. Should we integrate them in novel prognostic scoring systems?;Journal of Geriatric Oncology;2021-09